Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022   194,271      
Beginning balance at Dec. 31, 2022 $ 2,124,261 $ 1,943 $ 2,784,416 $ (652,876) $ (9,222)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 52,379     52,379  
Other comprehensive income (loss) (303)       (303)
Share-based compensation 22,842   22,842    
Stock option exercises (in shares)   1,362      
Stock option exercises 14,898 $ 14 14,884    
Issuances of common stock in connection with the vesting of restricted stock units (in shares)   337      
Issuances of common stock in connection with the vesting of restricted stock units (110) $ 3 (113)    
Issuances of common stock in connection with the employee stock purchase plan (in shares)   123      
Issuances of common stock in connection with the employee stock purchase plan 1,450 $ 1 1,449    
Issuances of common stock in connection with business acquisitions (in shares)   90      
Issuances of common stock in connection with business acquisitions 1,472 $ 1 1,471    
Ending balance (in shares) at Sep. 30, 2023   196,183      
Ending balance at Sep. 30, 2023 2,216,889 $ 1,962 2,824,949 (600,497) (9,525)
Beginning balance (in shares) at Jun. 30, 2023   196,031      
Beginning balance at Jun. 30, 2023 2,200,712 $ 1,960 2,814,424 (608,412) (7,260)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 7,915     7,915  
Other comprehensive income (loss) (2,265)       (2,265)
Share-based compensation 8,906   8,906    
Stock option exercises (in shares)   152      
Stock option exercises 1,621 $ 2 1,619    
Ending balance (in shares) at Sep. 30, 2023   196,183      
Ending balance at Sep. 30, 2023 $ 2,216,889 $ 1,962 2,824,949 (600,497) (9,525)
Beginning balance (in shares) at Dec. 31, 2023 196,671 196,671      
Beginning balance at Dec. 31, 2023 $ 2,254,112 $ 1,967 2,835,883 (576,813) (6,925)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 119,077     119,077  
Other comprehensive income (loss) (1,050)       (1,050)
Share-based compensation 27,216   27,216    
Stock option exercises (in shares)   1,691      
Stock option exercises 19,548 $ 17 19,531    
Issuance of common stock in connection with the Offering (Note 7), net of issuance costs (in shares)   6,000      
Issuance of common stock in connection with the Offering (Note 7), net of issuance costs 124,357 $ 60 124,297    
Issuances of common stock in connection with the vesting of restricted stock units (in shares)   701      
Issuances of common stock in connection with the vesting of restricted stock units (980) $ 6 (986)    
Issuances of common stock in connection with the employee stock purchase plan (in shares)   103      
Issuances of common stock in connection with the employee stock purchase plan 1,462 $ 1 1,461    
Settlement of accrued compensation liabilities through the issuance of common stock (in shares)   1,447      
Settlement of accrued compensation liabilities through the issuance of common stock $ 18,058 $ 15 18,043    
Ending balance (in shares) at Sep. 30, 2024 206,613 206,613      
Ending balance at Sep. 30, 2024 $ 2,561,800 $ 2,066 3,025,445 (457,736) (7,975)
Beginning balance (in shares) at Jun. 30, 2024   199,052      
Beginning balance at Jun. 30, 2024 2,367,497 $ 1,990 2,873,839 (499,091) (9,241)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 41,355     41,355  
Other comprehensive income (loss) 1,266       1,266
Share-based compensation 9,265   9,265    
Stock option exercises (in shares)   1,547      
Stock option exercises 18,058 $ 16 18,042    
Issuance of common stock in connection with the Offering (Note 7), net of issuance costs (in shares)   6,000      
Issuance of common stock in connection with the Offering (Note 7), net of issuance costs 124,357 $ 60 124,297    
Issuances of common stock in connection with the vesting of restricted stock units (in shares)   14      
Issuances of common stock in connection with the vesting of restricted stock units $ 2   2    
Ending balance (in shares) at Sep. 30, 2024 206,613 206,613      
Ending balance at Sep. 30, 2024 $ 2,561,800 $ 2,066 $ 3,025,445 $ (457,736) $ (7,975)